Personal information

No personal information available

Activities

Employment (1)

Ludwig-Maximilians-Universität München: Munich, DE

2000 to present | Honorary Professor (Institute for Immunology)
Employment
Source: Self-asserted source
Patrick Alexander Baeuerle

Works (40)

CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

Cancer Immunology Research
2024-08-01 | Journal article
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Data from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Data from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S10 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S10 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S11 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S11 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S12 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S12 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S13 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S13 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S14 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S14 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S15 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S15 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S2 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S2 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S3 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S3 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S4 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S4 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S5 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S5 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S6 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S6 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S7 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S7 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S8 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S8 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S9 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Figure S9 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Methods File S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Methods File S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Table S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Table S1 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Table S2 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

Supplementary Table S2 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024-08-01 | Preprint
Contributors: Naveen K. Mehta; Kavya Rakhra; Kristan A. Meetze; Bochong Li; Noor Momin; Jason Y.H. Chang; K. Dane Wittrup; Patrick A. Baeuerle; Jennifer S. Michaelson
Source: check_circle
Crossref

CD19-directed T cell–engaging antibodies for the treatment of autoimmune disease

Journal of Experimental Medicine
2024-05-06 | Journal article
Contributors: Jennifer S. Michaelson; Patrick A. Baeuerle
Source: check_circle
Crossref